Abstract
The objective of the study was to analyze the correlation between the mortality rate from cervical cancer with schooling, Gini index and Human Development Index (HDI). This is an epidemiological, retrospective, observational and ecological study carried out in the 161 intermediate regions of urban articulation in Brazil. The study was based on secondary data from DATASUS and the United Nations Development Program. The spatial analysis of mortality versus schooling, Gini index and HDI was performed. Most municipalities in Brazil with high mortality rate are located in the North and Northeast. In addition, it was observed that schooling, Gini index and HDI directly influence the increase or reduction of mortality. Knowing these fragilities and their distribution in Brazil is necessary to solve the problems and improve the indicators such as the mortality rate.
Highlights
IntroductionCervical cancer has increased its numbers of incidence and mortality in some countries and has been seen as a global public health problem
The object of this study was the mortality rate from cervical cancer as the dependent variable equivalent to the years 2008 to 2014, which are years available in the system. It was extracted from DATASUS in the Mortality Information System (SIM), the absolute number of women who died from cervical cancer, and from the 2010 Census of DATASUS, the number of women in Brazil from 25 to 64 years, to calculate the mortality rate
The independent variables were schooling, human development index (HDI) and Gini index, all extracted from the United Nations Development Program (UNDP)
Summary
Cervical cancer has increased its numbers of incidence and mortality in some countries and has been seen as a global public health problem. Cervical cancer can be prevented through effective screening programs, and treated for good prognosis if early diagnosis and effective oncology care are available. Better strategies are needed from public policies. Cervical cancer has a worldwide mortality of 275,100 cases per year, a prevalence of 440 million and an incidence of approximately 529,800 new cases each year, corresponding to the third most common cancer type in the world (Jemal et al, 2013)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
